Sun Pharma Outlook for the Week (March 15,2021 – March 19,2021)
SUNPHARMA Weekly Outlook and Analysis: For the Week: (March 15,2021 – March 19,2021) BSE: 524715| NSE: SUNPHARMA| ISIN: INE044A01036 | SECTOR: PHARMA Stock closed the
Home
Page 3057
Government Invites Bids for 392 Routes Under UDAN Scheme
The civil aviation ministry has invited bids for around 392 routes under the regional air connectivity scheme as part of continuing efforts to improve domestic
Over 6 Covid-19 Vaccines to Come Up in India, Says Health Minister
India is looking at all ‘serious’ post-vaccination side effects as it carries out the world’s largest coronavirus vaccination drive, a top medical expert said today
India’s Move to Deter Digital Monopolies to Hit Amazon, Walmart
India’s draft e-commerce rules to prevent the creation of “digital monopolies” and aid local startups may raise costs and stymie expansion plans at companies such
Quad Countries Agree to Send 1 Billion Vaccines Across Asia by 2022
Leaders of the United States, India, Australia, and Japan agreed to pool financing, manufacturing, and distribution capacity to send 1 billion Covid-19 vaccines across Asia
Tesla Investor Sues Elon Musk, Claims Tweets Violate SEC Settlement
Tesla Chief Executive Officer Elon Musk and the board of the electric car company have been sued by a shareholder who accused Musk of violating
Gautam Adani Beats Elon Musk, Jeff Bezos with Biggest Wealth Surge
Indian tycoon Gautam Adani has added more billions to his wealth than anyone else in the world this year on the back of investor excitement
Nazara Technologies IPO Opens March 17, Price Band Fixed at Rs 1,100
Rakesh Jhunjhunwala-backed Nazara Technologies is going to open its maiden public offer for subscription on March 17, within a price band of Rs 1,100-1,101 a
NCPCR Asks Netflix to Stop Streaming ‘Bombay Begums’
An Indian government agency for protecting child rights has asked Netflix Inc to immediately stop streaming its new drama series “Bombay Begums” after it reviewed
D2C Beauty Brand Juicy Chemistry Raises $6.3 Mn
Homegrown skin and hair care direct-to-consumer (D2C) brand Juicy Chemistry has raised $6.3 million in Series A funding round led by Belgium-based investment firm Verlinvest.